Dysglycemia induces abnormal circadian blood pressure variability

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Kumarasamy, Sivarajan ^b   Gopalakrishnan, Kathirvel ^b   Kim, Dong Hyun ^b   Abraham, Nader G ^b   Johnson, William D ^a   Joe, Bina ^b   Gupta, Alok K ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Adipokines; Adiponectin; Adipose tissue dysfunction; Caloric excess; Circadian blood pressure variability; Early CVD risk; Insulin resistance; Leptin; MCP 1; Pro inflammatory cytokines; Renin aldosterone angiotensin system; TNF

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE; GLUCOSE; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN, RAT; AUTACOID; BIOLOGICAL MARKER; CCL2 PROTEIN, RAT; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE VARIABILITY; BODY WEIGHT; CIRCADIAN RHYTHM; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HEART RATE; NONHUMAN; PULSE PRESSURE; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; DAHL SALT SENSITIVE RAT; DISEASE MODEL; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; LIPID DIET; METABOLISM; PATHOPHYSIOLOGY; TELEMETRY; TIME; WEIGHT GAIN;

ADIPONECTIN; ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHEMOKINE CCL2; CIRCADIAN RHYTHM; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; HEART RATE; INFLAMMATION; INFLAMMATION MEDIATORS; LEPTIN; PREDIABETIC STATE; RATS; RATS, INBRED DAHL; TELEMETRY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 81455162139     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-104     Document Type: Article

References (29)

1. Björntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996, 20(4):291-302. Review.
2. Lev-Ran A. Human obesity: an evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev 2001, 17(5):347-62. Review, 10.1002/dmrr.230, 11747140.
3. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004, 89(6):2583-9. 10.1210/jc.2004-0535, 15181027.
4. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006, 2(4):367-73. Review.
5. Blüher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 2009, 117(6):241-50. Review, 10.1055/s-0029-1192044, 19358089.
6. Blüher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010, 21(1):38-43. Review, 10.1097/MOL.0b013e3283346ccc, 19915462.
7. Gutierrez DA, Puglisi MJ, Hasty AH. Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Curr Diab Rep 2009, 9(1):26-32. 10.1007/s11892-009-0006-9, 2735041, 19192421.
8. Gupta AK, Cornelissen G, Greenway FL, Dhoopati V, Halberg F, Johnson WD. Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults. Cardiovasc Diabetol 2010, 9:58. 10.1186/1475-2840-9-58, 2955642, 20868493.
9. Gupta AK, Greenway FL, Cornelissen G, Pan W, Halberg F. Prediabetes is associated with abnormal circadian blood pressure variability. J Hum Hypertens 2008, 22(9):627-33. 10.1038/jhh.2008.32, 2573901, 18480832.
10. Gupta AK, Menon A, Brasher M, Johnson WD. Prediabetes: Prevalence, Pathogenesis, and Recognition of Enhanced Risk. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome Bagchi D, Nair S, , Chapter 5.
11. Gupta AK, Johnson WD. Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu. J Inflamm 2010, 7:36.
12. Gupta AK, McGlone M, Greenway FL, Johnson WD. Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile. Hypertens Res 2010, 33(9):905-10. 10.1038/hr.2010.91, 20535113.
13. Gupta AK, Brashear MM, Johnson WD. Coexisting prehypertension and prediabetes in healthy adults: a pathway for accelerated cardiovascular events. Hypertens Res 2011, 34(4):456-61. 10.1038/hr.2010.267, 21228791.
14. Joe B, Garrett MR, Dene H, Rapp JP. Substitution mapping of a blood pressure quantitative trait locus to a 2.73 Mb region on rat chromosome 1. J Hypertens 2003, 21:2077-2084. 10.1097/00004872-200311000-00017, 14597851.
15. Shin JY, Lee HR, Lee DC. Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol 2011, 10:30. 10.1186/1475-2840-10-30, 3098149, 21492487.
16. Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, Herrington DM. The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens 2011, 25(2):73-9. 10.1038/jhh.2010.91, 20944659.
17. Bray GA, et al. Obesity. Harrison's Principles of Internal Medicine 1998, 454-62. McGraw-Hill, New York, Fauci AS, Braunwald E, Isselbacher KJ, et al, 14.
18. Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 2009, 54(9):1847-56. 10.1007/s10620-008-0585-3, 19052866.
19. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008, 29(24):2959-71. 10.1093/eurheartj/ehn387, 18775919.
20. Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000, 35(6):1270-7.
21. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808. 296995, 14679176.
22. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, Fischer-Posovszky P, Barth TF, Dragun D, Skurk T, Hauner H, Blüher M, Unger T, Wolf AM, Knippschild U, Hombach V, Marx N. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008, 28:1304-1310. 10.1161/ATVBAHA.108.165100, 18420999.
23. Duffaut C, Galitzky J, Lafontan M, Bouloumie' A. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 2009, 384:482-485. 10.1016/j.bbrc.2009.05.002, 19422792.
24. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, Yoshimura K, Kadowaki T, Nagai R. CD8+ T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009, 15:914-920. 10.1038/nm.1964, 19633658.
25. Pacifico L, Di Renzo L, Anania C, Osborn JF, Ippoliti F, Schiavo E, Chiesa C. Increased T-helper interferon-gamma-secreting cells in obese children. Eur J Endocrinol 2006, 154:691-697. 10.1530/eje.1.02138, 16645016.
26. Linton MF, Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 2003, 27(Suppl 3):S35-S40.
27. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008, 34(1):2-11. 10.1016/j.diabet.2007.09.004, 18093861.
28. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006, 444(7121):860-7. 10.1038/nature05485, 17167474.
29. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008, 13:453-461. 10.2741/2692, 17981560.